Smith Risk Assessment Case Study by Top Papers

The paper relates that in recent decades, the wholesale pharmaceutical and drug industry has experienced tremendous growth; as reported by the Kaiser Family Foundation, spending in the U.S. for prescription drugs was $200.7 billion in 2005, almost 5 times more than the $40.3 billion spent in 1990 (Prescription Drug Trends, 2007). The paper discusses how due to increasing competitiveness in the wholesale drug industry, the Smith Drug Company has developed plans for implementing a new systems approach to support company sales and distribution. The paper presents a case study of the Smith Drug Company. Specifically, the case study provides critical inputs relevant to a risk assessment of the Smith Drug Company sales and distribution plan.